Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
McKinsey
Colorcon
Dow
Boehringer Ingelheim
Citi
Queensland Health
AstraZeneca
Medtronic
Harvard Business School

Generated: February 25, 2018

DrugPatentWatch Database Preview

Cilastatin sodium; imipenem - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for cilastatin sodium; imipenem and what is the scope of cilastatin sodium; imipenem freedom to operate?

Cilastatin sodium; imipenem
is the generic ingredient in two branded drugs marketed by Merck, Acs Dobfar, and Hospira Inc, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for cilastatin sodium; imipenem. Four suppliers are listed for this compound.
Summary for cilastatin sodium; imipenem
Pharmacology for cilastatin sodium; imipenem

US Patents and Regulatory Information for cilastatin sodium; imipenem

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck PRIMAXIN cilastatin sodium; imipenem POWDER;INTRAVENOUS 050587-002 Nov 26, 1985 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira Inc IMIPENEM AND CILASTATIN cilastatin sodium; imipenem POWDER;INTRAVENOUS 090825-002 Nov 16, 2011 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Acs Dobfar IMIPENEM AND CILASTATIN cilastatin sodium; imipenem POWDER;INTRAVENOUS 090577-002 Dec 21, 2011 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Merck PRIMAXIN cilastatin sodium; imipenem POWDER;INTRAMUSCULAR 050630-001 Dec 14, 1990 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Merck PRIMAXIN cilastatin sodium; imipenem POWDER;INTRAMUSCULAR 050630-002 Dec 14, 1990 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira Inc IMIPENEM AND CILASTATIN cilastatin sodium; imipenem POWDER;INTRAVENOUS 091007-001 Nov 16, 2011 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Merck PRIMAXIN cilastatin sodium; imipenem INJECTABLE;INJECTION 062756-002 Jan 8, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira Inc IMIPENEM AND CILASTATIN cilastatin sodium; imipenem POWDER;INTRAVENOUS 090825-001 Nov 16, 2011 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Merck PRIMAXIN cilastatin sodium; imipenem POWDER;INTRAVENOUS 050587-001 Nov 26, 1985 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Acs Dobfar IMIPENEM AND CILASTATIN cilastatin sodium; imipenem POWDER;INTRAVENOUS 090577-001 Dec 21, 2011 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for cilastatin sodium; imipenem

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck PRIMAXIN cilastatin sodium; imipenem POWDER;INTRAMUSCULAR 050630-001 Dec 14, 1990 ➤ Sign Up ➤ Sign Up
Merck PRIMAXIN cilastatin sodium; imipenem POWDER;INTRAVENOUS 050587-002 Nov 26, 1985 ➤ Sign Up ➤ Sign Up
Merck PRIMAXIN cilastatin sodium; imipenem POWDER;INTRAMUSCULAR 050630-002 Dec 14, 1990 ➤ Sign Up ➤ Sign Up
Merck PRIMAXIN cilastatin sodium; imipenem POWDER;INTRAVENOUS 050587-001 Nov 26, 1985 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Deloitte
Citi
Cantor Fitzgerald
Argus Health
Cerilliant
Johnson and Johnson
Queensland Health
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot